CRINETICS PHARMACEUTIC

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

11 9月 2023 15:01:22 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 9月 2023 05:00:48 条件 Nasdaq GlobeNewswire

Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-1 Study Evaluating Treatment of Patients with Acromegaly

10 9月 2023 09:00:04 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 8月 2023 16:34:32 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08 8月 2023 06:00:01 条件 Nasdaq GlobeNewswire

Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly

31 7月 2023 07:01:44 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 7月 2023 15:19:04 条件 Nasdaq GlobeNewswire

New Data Demonstrating Stable Biochemical and Symptom Levels with Two-Years of Oral Paltusotine Administration Presented at ENDO 2023

21 6月 2023 06:59:39 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 6月 2023 06:30:09 条件 Nasdaq GlobeNewswire

Crinetics to Highlight Broad Pipeline at ENDO 2023

09 6月 2023 06:30:08 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 5月 2023 15:21:55 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

04 5月 2023 15:05:12 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 4月 2023 15:31:01 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 3月 2023 15:37:50 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

28 2月 2023 15:05:39 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 2月 2023 16:21:42 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

10 2月 2023 07:01:33 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 1月 2023 15:48:48 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference

09 1月 2023 07:01:39 条件 Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 12月 2022 15:01:00 条件 Nasdaq GlobeNewswire